Frequency of Unrecognized Fabry Disease Among Young European-American and African-American Men With First Ischemic Stroke
- 1 January 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 41 (1), 78-81
- https://doi.org/10.1161/strokeaha.109.558320
Abstract
Background and Purpose— The cause of initial ischemic stroke in up to 30% of young patients remains unclear. Fabry disease, due to deficient α-galactosidase A (α-Gal A) activity, is a vascular endothelial glycosphingolipid storage disease typically presenting in childhood. With advancing age, patients develop renal, cardiac, and cerebrovascular disease and die prematurely. A European study suggested an increased prevalence of unrecognized Fabry disease in patients with cryptogenic stroke. We hypothesized that α-Gal A deficiency is a rare cause of initial early-onset ischemic stroke in men. Methods— The Stroke Prevention in Young Men Study enrolled >550 men (15 to 49 years) with first ischemic stroke in the Baltimore–Washington area in 2004 to 2007. Frozen plasma samples were assayed for α-Gal A activity, and DNA from patients with consistently low plasma α-Gal A activities were sequenced. Results— The study sample consisted of 558 men (42% African-American; median age 44 years). Stroke was cryptogenic in 154 men (40% African-American). In 10 patients with low plasma α-Gal A activities, DNA sequencing identified alterations in the α-Gal A gene in 2 patients. The polymorphism, D313Y, which results in low plasma enzyme activity, but near normal levels of cellular activity was seen in one European-American male. The Fabry disease-causing A143T mutation was seen in an African-American male with cryptogenic stroke (0.18% of all strokes: upper 95% CI=0.53%; 0.65% of cryptogenic strokes: upper 95% CI=1.92%). Conclusions— In this biracial population, unrecognized Fabry disease is a rare but treatable cause of initial ischemic stroke in young men.This publication has 25 references indexed in Scilit:
- Detection of Subclinical Fabry Disease in Patients Presenting With Hypertrophic CardiomyopathyJournal of the American College of Cardiology, 2007
- Females with Fabry disease frequently have major organ involvement: Lessons from the Fabry RegistryMolecular Genetics and Metabolism, 2007
- Middelheim Fabry Study (MiFaS): A retrospective Belgian study on the prevalence of Fabry disease in young patients with cryptogenic strokeClinical Neurology and Neurosurgery, 2007
- High Incidence of Later-Onset Fabry Disease Revealed by Newborn Screening*American Journal of Human Genetics, 2006
- dentification of Fabry’s disease by the screening of a-galactosidase A activity in male and female hemodialysis patientsClinical Nephrology, 2005
- Significance of screening for Fabry disease among male dialysis patientsClinical and Experimental Nephrology, 2005
- Results of a Nationwide Screening for Anderson-Fabry Disease among Dialysis PatientsJournal of the American Society of Nephrology, 2004
- Fabry disease: Characterization of ?-galactosidase A double mutations and the D313Y plasma enzyme pseudodeficiency alleleHuman Mutation, 2003
- Fabry disease: Detection of undiagnosed hemodialysis patients and identification of a “renal variant” phenotype1Kidney International, 2003
- Interrater Reliability of an Etiologic Classification of Ischemic StrokeStroke, 1995